Hap Trading, LLC Adamis Pharmaceuticals Corp Call Options Transaction History

Hap Trading, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	SELL	$0.34 - $0.57 $4,590 - $7,694	-13,500 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$0.55 - $0.73 $1,870 - $2,482	3,400 Added 33.66%	13,500 $1,000
Q4 2021 Feb 14, 2022	SELL	$0.57 - $1.23 $627 - $1,353	-1,100 Reduced 9.82%	10,100 $1,000
Q3 2021 Nov 10, 2021	SELL	$0.92 - $1.18 $19,412 - $24,898	-21,100 Reduced 65.33%	11,200 $1,000
Q2 2021 Aug 11, 2021	BUY	$0.66 - $1.23 $4,554 - $8,487	6,900 Added 27.17%	32,300 $7,000
Q1 2021 May 14, 2021	BUY	$0.54 - $1.79 $13,716 - $45,466	25,400 New	25,400 $2,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.